Use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina

1. A method for treating disorders of the outer retina in a patient in need thereof, which comprises administering a pharmaceutically effective amount of a β-adrenoceptor antagonist selected from the group consisting of: betaxolol (R or S or racemic), timolol, carteolol, levobunolol, metipranolol, befunolol, propranolol, metoporolol, atenolol, pendolol, and pinbutolol, wherein said disorder is selected from the group consisting of ARMD; RP; retinal detachment and tears; macular pucker; ischemia affecting the outer retina; damage associated with laser therapy (grid, focal and panretinal) including photodynamic therapy, thermal or cryotherapy; damage resulting from trauma to the eye; surgical (retinal translocation, subretinal surgery or vitrectomy) or light-induced iatrogenic retinopathy; and preservation of retinal transplant.

2. The method of claim 1 wherein the β-adrenoceptor antagonist is betaxolol or its R or S isomer.